NCT04859166View on ClinicalTrials.gov

Prospective Primary Human Lungcancer Organoids to Predict Treatment Response

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

October 1, 2022

Study Completion Date

October 1, 2022

Conditions
Lung Cancer
Interventions
PROCEDURE

Organoids

A part of the tumor of approximately 1 cm3 will be removed from the primary tumor.

Trial Locations (2)

6419 PC

Zuyderland Medical Center, Heerlen

6229 ET

Maastro, Maastricht

All Listed Sponsors
lead

Maastricht Radiation Oncology

OTHER

NCT04859166 - Prospective Primary Human Lungcancer Organoids to Predict Treatment Response | Biotech Hunter | Biotech Hunter